CKD in Hispanics: Baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC Studies.

BACKGROUND Little is known regarding chronic kidney disease (CKD) in Hispanics. We compared baseline characteristics of Hispanic participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC (H-CRIC) Studies with non-Hispanic CRIC participants. STUDY DESIGN Cross-sectional analysis. SETTING & PARTICIPANTS Participants were aged 21-74 years with CKD using age-based estimated glomerular filtration rate (eGFR) at enrollment into the CRIC/H-CRIC Studies. H-CRIC included Hispanics recruited at the University of Illinois in 2005-2008, whereas CRIC included Hispanics and non-Hispanics recruited at 7 clinical centers in 2003-2007. FACTOR Race/ethnicity. OUTCOMES Blood pressure, angiotensin-converting enzyme (ACE)-inhibitor/angiotensin receptor blocker (ARB) use, and CKD-associated complications. MEASUREMENTS Demographic characteristics, laboratory data, blood pressure, and medications were assessed using standard techniques and protocols. RESULTS Of H-CRIC/CRIC participants, 497 were Hispanic, 1,650 were non-Hispanic black, and 1,638 were non-Hispanic white. Low income and educational attainment were nearly twice as prevalent in Hispanics compared with non-Hispanics (P < 0.01). Hispanics had self-reported diabetes (67%) more frequently than non-Hispanic blacks (51%) and whites (40%; P < 0.01). Blood pressure >130/80 mm Hg was more common in Hispanics (62%) than blacks (57%) and whites (35%; P < 0.05), and abnormalities in hematologic, metabolic, and bone metabolism parameters were more prevalent in Hispanics (P < 0.05), even after stratifying by entry eGFR. Hispanics had the lowest use of ACE inhibitors/ARBs among the high-risk subgroups, including participants with diabetes, proteinuria, and blood pressure >130/80 mm Hg. Mean eGFR was lower in Hispanics (39.6 mL/min/1.73 m(2)) than in blacks (43.7 mL/min/1.73 m(2)) and whites (46.2 mL/min/1.73 m(2)), whereas median proteinuria was higher in Hispanics (protein excretion, 0.72 g/d) than in blacks (0.24 g/d) and whites (0.12 g/d; P < 0.01). LIMITATIONS Generalizability; observed associations limited by residual bias and confounding. CONCLUSIONS Hispanics with CKD in the CRIC/H-CRIC Studies are disproportionately burdened with lower socioeconomic status, more frequent diabetes mellitus, less ACE-inhibitor/ARB use, worse blood pressure control, and more severe CKD and associated complications than their non-Hispanic counterparts.

[1]  M. Rocco,et al.  Differences in mortality among Mexican-American, Puerto Rican, and Cuban-American dialysis patients in the United States. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  M. Harris,et al.  Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes. , 2001, Diabetes care.

[3]  H. Feldman,et al.  Renal failure among male Hispanics in the United States. , 1995, American journal of public health.

[4]  Keith C. Norris,et al.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. , 2001, JAMA.

[5]  E. Perez-stable,et al.  Creatinine levels among Mexican Americans, Puerto Ricans, and Cuban Americans in the Hispanic Health and Nutrition Examination Survey. , 2004, Kidney international.

[6]  C. Schmid,et al.  Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. , 2011, Kidney international.

[7]  E. Boyko,et al.  Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  T. Hostetter,et al.  Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. , 2004, Journal of the American Society of Nephrology : JASN.

[9]  Trends in Prevalence, Awareness, Treatment, and Control of Hypertension in the United States, 1988-2000 , 2003 .

[10]  Rui Mei,et al.  Latino populations: a unique opportunity for the study of race, genetics, and social environment in epidemiological research. , 2005, American journal of public health.

[11]  Jennifer Y. Liu,et al.  Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes , 2004, Journal of General Internal Medicine.

[12]  A. Go,et al.  Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[13]  R. Foley,et al.  NHANES III: influence of race on GFR thresholds and detection of metabolic abnormalities. , 2007, Journal of the American Society of Nephrology : JASN.

[14]  C Zoccali,et al.  The valuable contribution of observational studies to nephrology. , 2007, Kidney international.

[15]  B. Brenner,et al.  Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL. , 2006, Kidney international.

[16]  M. Wolf,et al.  Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey. , 2011, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[17]  L. Franzini,et al.  Understanding the Hispanic paradox. , 2001, Ethnicity & disease.

[18]  D. Molony,et al.  Survival advantage of Hispanic patients initiating dialysis in the United States is modified by race. , 2005, Journal of the American Society of Nephrology : JASN.

[19]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[20]  Eliseo J. Perez-Stable,et al.  Development of a Short Acculturation Scale for Hispanics , 1987 .

[21]  A. Go,et al.  Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[22]  J. Sundquist,et al.  Country of birth, acculturation status and abdominal obesity in a national sample of Mexican-American women and men. , 2000, International journal of epidemiology.

[23]  K. Norris,et al.  Racial differences in mortality among those with CKD. , 2008, Journal of the American Society of Nephrology : JASN.

[24]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[25]  Keith C. Norris,et al.  Race, gender, and socioeconomic disparities in CKD in the United States. , 2008, Journal of the American Society of Nephrology : JASN.

[26]  Betsy Guzman,et al.  The Hispanic Population. Census 2000 Brief. , 2001 .

[27]  B. Davis,et al.  Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2005, Archives of internal medicine.

[28]  J. Coresh,et al.  Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  G. Beck,et al.  The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .

[30]  R. Wolfe,et al.  Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  N. Powe Let's get serious about racial and ethnic disparities. , 2008, Journal of the American Society of Nephrology : JASN.

[32]  M. Joffe,et al.  Revisiting survival differences by race and ethnicity among hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study. , 2006, Journal of the American Society of Nephrology : JASN.

[33]  N. Risch,et al.  Differences in Albuminuria Between Hispanics and Whites: An Evaluation by Genetic Ancestry and Country of Origin: The Multi-Ethnic Study of Atherosclerosis , 2010, Circulation. Cardiovascular genetics.

[34]  M. Wolf,et al.  Low socioeconomic status associates with higher serum phosphate irrespective of race. , 2010, Journal of the American Society of Nephrology : JASN.

[35]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[36]  W. Post,et al.  Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA). , 2004, American journal of hypertension.

[37]  A. Go,et al.  The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. , 2003, Journal of the American Society of Nephrology : JASN.

[38]  Charles Maynard,et al.  Racial differences in diabetic nephropathy, cardiovascular disease, and mortality in a national population of veterans. , 2003, Diabetes care.

[39]  M. Rocco,et al.  Survival advantage for adult Hispanic hemodialysis patients? Findings from the end-stage renal disease clinical performance measures project. , 2003, Journal of the American Society of Nephrology : JASN.

[40]  G. Chertow,et al.  Characteristics of Uninsured Americans with Chronic Kidney Disease , 2009, Journal of General Internal Medicine.

[41]  Anna C. Porter,et al.  Chronic kidney disease in United States Hispanics: a growing public health problem. , 2009, Ethnicity & disease.

[42]  S. Haffner,et al.  Excess incidence of treatment of end-stage renal disease in Mexican Americans. , 1988, American journal of epidemiology.